Claudia Sandomenico Selected Research

Claudia Sandomenico Research Topics

Disease

14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2020 - 01/2011
8	Neoplasms (Cancer) 10/2022 - 03/2014
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 01/2017
6	Colorectal Neoplasms (Colorectal Cancer) 03/2011 - 09/2006
3	Diarrhea 01/2016 - 09/2006
2	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2017
2	Circulating Neoplastic Cells 01/2022 - 11/2012
2	Disease Progression 01/2022 - 07/2013
2	Lung Neoplasms (Lung Cancer) 07/2020 - 10/2019
2	Hemorrhage 01/2020 - 01/2016
2	Vomiting 01/2019 - 09/2006
2	Adenocarcinoma 09/2017 - 01/2016
2	Stomatitis 01/2008 - 09/2006
1	Melanoma (Melanoma, Malignant) 10/2022
1	Adenocarcinoma of Lung 01/2022
1	Deglutition Disorders (Dysphagia) 01/2019
1	Alopecia (Baldness) 01/2019
1	Nausea 01/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2019
1	Hypertension (High Blood Pressure) 01/2016
1	Pruritus (Itching) 06/2012
1	Jaundice (Icterus) 06/2012
1	Cholangitis 06/2012
1	Thrombosis (Thrombus) 03/2011
1	Neutropenia 03/2011
1	Carcinoma (Carcinomatosis) 03/2011
1	Margins of Excision 03/2011
1	Venous Thrombosis (Deep-Vein Thrombosis) 03/2011
1	Stomach Neoplasms (Stomach Cancer) 10/2009
1	Colonic Neoplasms (Colon Cancer) 01/2008

Drug/Important Bio-Agent (IBA)

6	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2011 - 09/2006
5	Fluorouracil (Carac)FDA LinkGeneric 03/2011 - 09/2006
5	Leucovorin (Folinic Acid)FDA Link 03/2011 - 09/2006
4	PlatinumIBA 09/2020 - 07/2013
4	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2008
4	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2011
4	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 07/2013
4	Gefitinib (Iressa)FDA Link 01/2014 - 01/2011
4	Irinotecan (Camptosar)FDA LinkGeneric 03/2011 - 09/2006
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022 - 01/2014
3	Tyrosine Kinase InhibitorsIBA 01/2014 - 01/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2014
2	Angiogenesis InhibitorsIBA 01/2021 - 01/2020
2	pembrolizumabIBA 09/2020 - 10/2019
2	nintedanibIBA 09/2017 - 01/2016
2	Docetaxel (Taxotere)FDA Link 09/2017 - 01/2016
2	Gemcitabine FDA Link 03/2014 - 07/2013
2	Capecitabine (Xeloda)FDA Link 07/2008 - 01/2008
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2022
1	TrabectedinIBA 01/2022
1	PM 01183IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	big gastrinIBA 01/2021
1	NivolumabIBA 09/2020
1	Monoclonal AntibodiesIBA 07/2020
1	atezolizumabIBA 07/2020
1	RamucirumabIBA 01/2020
1	B7-H1 AntigenIBA 10/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2017
1	EnzymesIBA 01/2016
1	AfatinibIBA 01/2016
1	Pemetrexed (MTA)FDA Link 03/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2013
1	Cetuximab (Erbitux)FDA Link 02/2012
1	raltitrexed (D 1694)IBA 03/2011
1	AcidsIBA 10/2009
1	Platinum Compounds (Compounds, Platinum)IBA 02/2009
1	ProdrugsIBA 01/2008
1	XELOXIBA 01/2008
1	Cholinergic Agents (Cholinergics)IBA 09/2006

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 10/2022 - 07/2008
4	Therapeutics 01/2022 - 07/2013
2	Immunotherapy 10/2022 - 09/2020
2	Radiotherapy 01/2017 - 03/2011
1	Intravenous Infusions 01/2020
1	Pancreaticoduodenectomy 06/2012
1	Neoadjuvant Therapy 06/2012
1	Drug Tapering 03/2011
1	Catheters 03/2011